Chance Pharmaceuticals
Hangzhou
About Chance Pharmaceuticals
Chance Pharmaceuticals provides, discovers, develops, and commercializes inhalation therapies for the world’s debilitating diseases such as chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $51.3M
- Last round: Series Unknown (Mar 2025)
- Website: chancepharmaceuticals.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/chance-pharmaceuticals-150422 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.